Evidence map›Paper›PMID 26305225›Full record

ArticlePloS one2015

Nucleosome Organization in Human Embryonic Stem Cells.

Puya G Yazdi, Brian A Pedersen, Jared F Taylor, Omar S Khattab, Yu-Han Chen, Yumay Chen, Steven E Jacobsen, Ping H Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Puya G YazdiUC Irvine Diabetes Center, University of California Irvine, Irvine, California, United States of America; Sue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, California, United States of America; Department of Medicine, University of California Irvine, Irvine, California, United States of America.
Brian A PedersenUC Irvine Diabetes Center, University of California Irvine, Irvine, California, United States of America; Sue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, California, United States of America; Department of Medicine, University of California Irvine, Irvine, California, United States of America.
Jared F TaylorUC Irvine Diabetes Center, University of California Irvine, Irvine, California, United States of America; Sue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, California, United States of America; Department of Medicine, University of California Irvine, Irvine, California, United States of America.
Omar S KhattabUC Irvine Diabetes Center, University of California Irvine, Irvine, California, United States of America; Sue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, California, United States of America.
Yu-Han ChenUC Irvine Diabetes Center, University of California Irvine, Irvine, California, United States of America; Sue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, California, United States of America; Department of Medicine, University of California Irvine, Irvine, California, United States of America.
Yumay ChenUC Irvine Diabetes Center, University of California Irvine, Irvine, California, United States of America; Sue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, California, United States of America; Department of Medicine, University of California Irvine, Irvine, California, United States of America.
Steven E JacobsenDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, United States of America; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California, United States of America; Howard Hughes Medical Institute, University of California Los Angeles, Los Angeles, California, United States of America.
Ping H WangUC Irvine Diabetes Center, University of California Irvine, Irvine, California, United States of America; Sue and Bill Gross Stem Cell Research Center, University of California Irvine, Irvine, California, United States of America; Department of Medicine, University of California Irvine, Irvine, California, United States of America; Department of Biological Chemistry, University of California Irvine, Irvine, California, United States of America; Department of Physiology & Biophysics, University of California Irvine, Irvine, California, United States of America.
University of California, Irvine · USUniversity of California, Los Angeles · US

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001414
6 · The paper itself

Abstract

The fundamental repeating unit of eukaryotic chromatin is the nucleosome. Besides being involved in packaging DNA, nucleosome organization plays an important role in transcriptional regulation and cellular identity. Currently, there is much debate about the major determinants of the nucleosome architecture of a genome and its significance with little being known about its role in stem cells. To address these questions, we performed ultra-deep sequencing of nucleosomal DNA in two human embryonic stem cell lines and integrated our data with numerous epigenomic maps. Our analyses have revealed that the genome is a determinant of nucleosome organization with transcriptionally inactive regions characterized by a "ground state" of nucleosome profiles driven by underlying DNA sequences. DNA sequence preferences are associated with heterogeneous chromatin organization around transcription start sites. Transcription, histone modifications, and DNA methylation alter this "ground state" by having distinct effects on both nucleosome positioning and occupancy. As the transcriptional rate increases, nucleosomes become better positioned. Exons transcribed and included in the final spliced mRNA have distinct nucleosome profiles in comparison to exons not included at exon-exon junctions. Genes marked by the active modification H3K4m3 are characterized by lower nucleosome occupancy before the transcription start site compared to genes marked by the inactive modification H3K27m3, while bivalent domains, genes associated with both marks, lie exactly in the middle. Combinatorial patterns of epigenetic marks (chromatin states) are associated with unique nucleosome profiles. Nucleosome organization varies around transcription factor binding in enhancers versus promoters. DNA methylation is associated with increasing nucleosome occupancy and different types of methylations have distinct location preferences within the nucleosome core particle. Finally, computational analysis of nucleosome organization alone is sufficient to elucidate much of the circuitry of pluripotency. Our results, suggest that nucleosome organization is associated with numerous genomic and epigenomic processes and can be used to elucidate cellular identity.

Indexed as

Binding SitesCell DifferentiationCell LineComputational BiologyConserved SequenceDNA MethylationEnhancer Elements, GeneticEpigenesis, GeneticHistonesHuman Embryonic Stem CellsHumansNucleosomesNucleotide MotifsTranscription FactorsHistonesNucleosomesTranscription Factors

Identifiers

PMID26305225
PMCPMC4549264
OpenAlexW1898890134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.